A clinical guide for practitioners on longevity medicine — covering biological age testing, NAD+ optimization, senolytics, VO2max, and longevity pharmacology including metformin and rapamycin.
A practitioner’s guide to compounding pharmacy partnerships — covering 503A vs. 503B regulations, quality indicators, common formulations, prescription writing, and managing pharmacy transitions.
A clinical guide for hormone practitioners on sexual health — covering ED evaluation and treatment, PDE5 inhibitors, low libido in women, genitourinary syndrome of menopause, and psychosexual factors.
A guide for practitioners on informed consent in hormone therapy — covering legal requirements, TRT-specific consent, off-label use documentation, compounded medication consent, and best practices.
A guide for practitioners opening telehealth weight loss and metabolic health clinics — covering GLP-1 prescribing, patient intake, clinical scope, ABOM certification, and long-term care protocols.
A clinical and patient communication guide for practitioners on bioidentical hormone replacement therapy — covering FDA-approved options, compounded BHRT, safety evidence, and informed consent.
A growth strategy guide for hormone practitioners on building referral networks — covering ideal referral partners, outreach approach, seamless referral experiences, and digital collaboration.
A practitioner’s guide to DHT, androgenetic alopecia, finasteride, and hair loss management — covering the biochemistry, 5AR inhibitors, post-finasteride syndrome, and complementary treatments.
A clinical guide for hormone practitioners on optimizing sleep — covering sleep-testosterone research, sleep architecture, sleep apnea, clinical assessment tools, and evidence-based interventions.
An evidence-based clinical guide for practitioners managing PCOS — covering phenotypes, insulin-testosterone connection, diagnostic workup, lifestyle interventions, and pharmacological approaches.
